- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4425 - Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
Patent holdings for IPC class A61K 31/4425
Total number of patents in this class: 466
10-year publication summary
|
45
|
33
|
43
|
41
|
46
|
40
|
31
|
31
|
23
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Société des Produits Nestlé S.A. | 10107 |
18 |
| Amneal Complex Products Research LLC | 62 |
16 |
| The Procter & Gamble Company | 21861 |
9 |
| The Research Foundation for The State University of New York | 1738 |
9 |
| Nocion Therapeutics, Inc. | 51 |
9 |
| Lion Corporation | 738 |
7 |
| Colgate-Palmolive Company | 5749 |
6 |
| Inspired Material Strategies, LLC | 13 |
6 |
| Board of Regents, The University of Texas System | 6102 |
5 |
| Arms Pharmaceutical, LLC | 11 |
5 |
| Unicycive Therapeutics, Inc. | 28 |
5 |
| The Regents of the University of California | 20720 |
4 |
| Battelle Memorial Institute | 2603 |
4 |
| Aarhus Universitet | 448 |
4 |
| Ardelyx, Inc. | 119 |
4 |
| Chiesi Farmaceutici S.p.A. | 959 |
4 |
| Enanta Pharmaceuticals, Inc. | 429 |
4 |
| Farmak International Holding GmbH | 6 |
4 |
| Occurx Pty Ltd | 11 |
4 |
| Schülke & Mayr GmbH | 151 |
4 |
| Other owners | 335 |